Acurx Pharmaceuticals, Inc.

ACXP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Sep 17, 2026
424B3 Sep 17, 2026 424B3
S-1 Sep 8, 2026 S-1
ARS Sep 1, 2026 ARS
DEFA14A Sep 1, 2026 DEFA14A
DEF 14A Sep 1, 2026 DEF 14A
10-Q Aug 13, 2026 10-Q
424B3 May 12, 2026 424B3
424B3 May 12, 2026 424B3
EFFECT May 11, 2026
EFFECT May 11, 2026
10-Q May 11, 2026 10-Q
CORRESP May 7, 2026
CORRESP May 7, 2026
UPLOAD May 7, 2026
UPLOAD May 7, 2026
S-1 May 4, 2026 FORM S-1
S-1 May 4, 2026 FORM S-1
D Apr 29, 2026
4 Apr 22, 2026 OWNERSHIP DOCUMENT
4 Apr 22, 2026 OWNERSHIP DOCUMENT
4 Apr 22, 2026 OWNERSHIP DOCUMENT
4 Apr 22, 2026 OWNERSHIP DOCUMENT
4 Apr 22, 2026 OWNERSHIP DOCUMENT
4 Apr 22, 2026 OWNERSHIP DOCUMENT
← Newer Page 1 of 10 · 243 filings Older →